T-PGI

Serial Number 98301836
606

Registration Progress

Application Filed
Dec 6, 2023
Under Examination
Oct 29, 2024
Approved for Publication
Sep 3, 2024
Published for Opposition
Sep 3, 2024
Registered

Trademark Image

T-PGI

Basic Information

Serial Number
98301836
Filing Date
December 6, 2023
Published for Opposition
September 3, 2024
Abandonment Date
June 2, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 2, 2025
Classes
001 005 042 044

Rights Holder

Tome Biosciences, Inc.

03
Address
100 Talcott Avenue
Watertown, MA 02472

Ownership History

Tome Biosciences, Inc.

Original Applicant
03
Watertown, MA

Tome Biosciences, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Jennifer Kwon

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Jun 2, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 2, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 29, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 3, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 3, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 14, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 1, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 6, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 6, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapy
Class 005
Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeutics
Class 042
Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineering
Class 044
Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapies

Additional Information

Pseudo Mark
TOME PGI

Classification

International Classes
001 005 042 044